What is the current Price Target for the NextCure, Inc. stock?

The average NextCure, Inc. target price is $20.40. This is 300.79% higher than the current stock price. The highest price target is 312.57%, the lowest is 296.86%. 3 Analysts have issued a price target NextCure, Inc. 2027 .

How high will the NextCure, Inc. stock rise?

No reliable answer can be given as to how high the NextCure, Inc. stock will rise. The performance of stocks, including the NextCure, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the NextCure, Inc. stock today?

The performance of NextCure, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the NextCure, Inc. stock fall?

The decline in NextCure, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

NextCure, Inc. Forecast, price target & analysts

$5.09

2.62%

Nasdaq, Oct 02, 04:00 pm EDT. Closed.

ISIN

US65343E1082

Symbol

NXTC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

NextCure, Inc. Target price 2026 - Analyst rating & recommendation

NextCure, Inc. Classifications & Recommendation

Buy

86%

Hold

14%

NextCure, Inc. Price Target

Target Price	$20.40
Price	$5.09
Potential	300.79% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target NextCure, Inc. 2027 . The average NextCure, Inc. target price is $20.40. This is 300.79% register free of charge higher than the current stock price. The highest price target is $21.00 312.57% register free of charge , the lowest is $20.20 296.86% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend NextCure, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the NextCure, Inc. stock has an average upside potential 2027 of 300.79% register free of charge . Most analysts recommend the NextCure, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

4 Analysts have issued a NextCure, Inc. forecast for earnings per share. The average NextCure, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-6.01 15.94% unlock
2028	$-1.24 79.37% unlock
2029	$-5.39 334.68% unlock
2030	$-5.24 2.78% unlock

Current	-0.63	184.56%
2026	-0.71 12.29% unlock
2027	-0.85 19.72% unlock
2028	-4.09 381.18% unlock
2029	-0.95 76.77% unlock
2030	-0.97 2.11% unlock

NextCure, Inc....

Current NextCure, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
LUCID CAPITAL MARKETS	Locked ➜ Locked	Locked	May 11 2026
Ladenburg Thalmann	Locked ➜ Locked	Locked	Nov 07 2025
Piper Sandler	Locked ➜ Locked	Locked	Jul 15 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 17 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 07 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 11 2024

Analyst Rating	Date
Locked LUCID CAPITAL MARKETS: Locked ➜ Locked	May 11 2026
Locked Ladenburg Thalmann: Locked ➜ Locked	Nov 07 2025
Locked Piper Sandler: Locked ➜ Locked	Jul 15 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 17 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 07 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 11 2024

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 81.89%

Rheinmetall 70.55%

Tencent Holdings Ltd. 61.28%

Adyen 56.67%

Uber Technologies 51.26%

BYD 50.30%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now